Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ole De Backer , Darren Mylotte , Colum Owens , et al Added: 2 years ago
In this symposium, part of Transcatheter Interventions Online 2022, Dr Colum Owens and Prof Mark Spence from Royal Victoria Hospital, Belfast perform a TAVI implantation with a focus on preserving future coronary access. Before the live case, Prof Ole De Backer and Dr Darren Mylotte will present on current trends in TAVI and key considerations for first choice valve in low-risk populations. … View more
Foreword

Article

Author(s): Samin K Sharma Added: 3 years ago
Interventional cardiology has just celebrated its 30th anniversary. Since its inception in 1977, when Andrea Greuntzig performed his first angioplasty in Zurich, the field has seen continuous and at times exponential growth. However, these advances were challenged by the negative results of few well designed randomised clinical trials in 2006–2007 (OAT trial, BASKETLATE trial, SCAAR trial,… View more
Author(s): Martin B Leon Added: 3 years ago
Since the first treatment of a patient with severe stenosis of the left anterior descending coronary artery using the percutaneous balloon angioplasty technique, pioneered by Andreas Gruentzig more than 25 years ago, the thriving subspeciality of lesser-invasive transcatheter therapeutics has become an important treatment alternative in patients with cardiovascular disease (CVD). Although balloon… View more
Author(s): Pascal Thériault-Lauzier , Marco Spaziano , Beatriz Vaquerizo , et al Added: 3 years ago
Valvular Disease Aortic valve Severe symptomatic aortic stenosis (AS) bears a dismal prognosis. The mean survival is 2.0 to 4.7 years after the onset of angina, 0.8 to 3.8 years after the onset of syncope and 0.5 to 2.8 years after the onset of congestive heart failure.1 Surgical aortic valve replacement (SAVR) is the mainstay of treatment for these patients.2 In the last decade transcatheter… View more
Author(s): Nina Wunderlich , Harald Küx , Felix Kreidel , et al Added: 3 years ago
Over the past 30 years, several percutaneous transcatheter technologies and devices for interventions in structural heart diseases (SHDs) have been introduced (see Table 1). There are numerous technologies that are in development or are currently being used to treat patients with SHD that use transcatheter techniques. The variety of percutaneous treatment approaches has led to a revolution and… View more
Author(s): Satinder K Sandhu Added: 3 years ago
Over the last three decades numerous transcatheter therapies for the treatment of congenital heart disease (CHD) have been developed. Interatrial Septal Defect Balloon atrial septostomy has been performed in patients with transposition physiology and in patients where egress of blood is needed from the left or the right atrium and in adults with pulmonary vascular disease where the creation of… View more
Author(s): Ulrich Schäfer Added: 3 years ago
As the field of interventional cardiology has grown, so too has interest in mitigating severe adverse outcomes such as stroke. Unfortunately, the risk of stroke is increased by many underlying disease conditions (atrial fibrillation, patent foramen ovale, carotid artery disease and other vascular disease affecting brain perfusion, etc.), making clear differentiation between cardiac intervention… View more
Author(s): Phyo Htet Khaing , G Louise Buchanan , Vijay Kunadian Added: 3 years ago
Many profound physiological changes take place in the cardiovascular system during pregnancy to meet the increased metabolic demands of both the mother and foetus. Such changes include an increase in circulating blood volume and cardiac output and decreases in systemic vascular resistance, blood pressure and hypercoagulation.1,2 The increase in circulatory burden during pregnancy and the… View more